SCLXWNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$532.511 K
$0.06 -30.33%
Close of 22 Sept 2026
Revenue
$30.3M
#2881 by revenue
Earnings
-$374.1M
Loss-making
Shares outstanding
8,493,000
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Scilex lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Scilex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.